Key result
The abstract outlines the objective to assess whether clopidogrel has a differential effect on secondary stroke prevention by smoking status, but reports no results.
No takes yet. Share an insight, caveat, or question.
No evidence to guide clopidogrel use by smoking status for secondary stroke prevention; leaves open differential efficacy.
Ovbiagele et al. (2017) studied Stroke. Clopidogrel vs. Smoking status (smokers vs nonsmokers) was evaluated on Secondary stroke prevention. The abstract outlines the objective to assess whether clopidogrel has a differential effect on secondary stroke prevention by smoking status, but reports no results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: